For example, in an amyotrophic lateral sclerosis (ALS) mouse model, treatment with MTK blocked GPR17 and increased differentiation of OPCs from spinal cord samples (Bonfanti et al., 2020). Here, GPR17 is linked to amyotrophic lateral sclerosis.